Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 May;123(5):e783-9.
doi: 10.1542/peds.2008-1871.

Recognition of a Kawasaki disease shock syndrome

John T Kanegaye  1 , Matthew S Wilder, Delaram Molkara, Jeffrey R Frazer, Joan Pancheri, Adriana H Tremoulet, Virginia E Watson, Brookie M Best, Jane C Burns
Affiliations

Recognition of a Kawasaki disease shock syndrome

John T Kanegaye et al. Pediatrics. 2009 May.

Abstract

Objective: We sought to define the characteristics that distinguish Kawasaki disease shock syndrome from hemodynamically normal Kawasaki disease.

Methods: We collected data prospectively for all patients with Kawasaki disease who were treated at a single institution during a 4-year period. We defined Kawasaki disease shock syndrome on the basis of systolic hypotension for age, a sustained decrease in systolic blood pressure from baseline of > or =20%, or clinical signs of poor perfusion. We compared clinical and laboratory features, coronary artery measurements, and responses to therapy and analyzed indices of ventricular systolic and diastolic function during acute and convalescent Kawasaki disease.

Results: Of 187 consecutive patients with Kawasaki disease, 13 (7%) met the definition for Kawasaki disease shock syndrome. All received fluid resuscitation, and 7 (54%) required vasoactive infusions. Compared with patients without shock, patients with Kawasaki disease shock syndrome were more often female and had larger proportions of bands, higher C-reactive protein concentrations, and lower hemoglobin concentrations and platelet counts. Evidence of consumptive coagulopathy was common in the Kawasaki disease shock syndrome group. Patients with Kawasaki disease shock syndrome more often had impaired left ventricular systolic function (ejection fraction of <54%: 4 of 13 patients [31%] vs 2 of 86 patients [4%]), mitral regurgitation (5 of 13 patients [39%] vs 2 of 83 patients [2%]), coronary artery abnormalities (8 of 13 patients [62%] vs 20 of 86 patients [23%]), and intravenous immunoglobulin resistance (6 of 13 patients [46%] vs 32 of 174 patients [18%]). Impairment of ventricular relaxation and compliance persisted among patients with Kawasaki disease shock syndrome after the resolution of other hemodynamic disturbances.

Conclusions: Kawasaki disease shock syndrome is associated with more-severe laboratory markers of inflammation and greater risk of coronary artery abnormalities, mitral regurgitation, and prolonged myocardial dysfunction. These patients may be resistant to immunoglobulin therapy and require additional antiinflammatory treatment.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Recognition of KDSS over 4 years, according to date of presentation.
See this image and copyright information in PMC

References

    1. Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease: a 10- to 21-year follow-up study of 594 patients. Circulation. 1996;94(6):1379–1385. - PubMed
    1. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110(17):2747–2771. - PubMed
    1. Ralston M, Hazinski MF, Zaritsky AL, Schexnayder SM, Kleinman ME. Pediatric Advanced Life Support Provider Manual. American Heart Association; Dallas, TX: 2006.
    1. Dieckmann RA. Pediatric assessment. In: Gausche-Hill M, Fuchs S, Yamamoto L, editors. APLS: The Pediatric Emergency Medicine Resource. 4th ed. Jones and Bartlett; Sudbury, MA: 2007. pp. 20–51.
    1. Fitzmaurice L, Gerardi MJ. Cardiovascular system. In: Gausche-Hill M, Fuchs S, Yamamoto L, editors. APLS: The Pediatric Emergency Medicine Resource. 4th ed. Jones and Bartlett; Sudbury, MA: 2007. pp. 106–145.

Publication types